Literature DB >> 21536733

A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets.

Diogo S Castro1, Ben Martynoga, Carlos Parras, Vidya Ramesh, Emilie Pacary, Caroline Johnston, Daniela Drechsel, Mélanie Lebel-Potter, Laura Galinanes Garcia, Charles Hunt, Dirk Dolle, Angela Bithell, Laurence Ettwiller, Noel Buckley, François Guillemot.   

Abstract

Proneural genes such as Ascl1 are known to promote cell cycle exit and neuronal differentiation when expressed in neural progenitor cells. The mechanisms by which proneural genes activate neurogenesis--and, in particular, the genes that they regulate--however, are mostly unknown. We performed a genome-wide characterization of the transcriptional targets of Ascl1 in the embryonic brain and in neural stem cell cultures by location analysis and expression profiling of embryos overexpressing or mutant for Ascl1. The wide range of molecular and cellular functions represented among these targets suggests that Ascl1 directly controls the specification of neural progenitors as well as the later steps of neuronal differentiation and neurite outgrowth. Surprisingly, Ascl1 also regulates the expression of a large number of genes involved in cell cycle progression, including canonical cell cycle regulators and oncogenic transcription factors. Mutational analysis in the embryonic brain and manipulation of Ascl1 activity in neural stem cell cultures revealed that Ascl1 is indeed required for normal proliferation of neural progenitors. This study identified a novel and unexpected activity of the proneural gene Ascl1, and revealed a direct molecular link between the phase of expansion of neural progenitors and the subsequent phases of cell cycle exit and neuronal differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536733      PMCID: PMC3084027          DOI: 10.1101/gad.627811

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  108 in total

1.  Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways.

Authors:  Carol Schuurmans; Olivier Armant; Marta Nieto; Jan M Stenman; Olivier Britz; Natalia Klenin; Craig Brown; Lisa-Marie Langevin; Julie Seibt; Hua Tang; James M Cunningham; Richard Dyck; Christopher Walsh; Kenny Campbell; Franck Polleux; François Guillemot
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

2.  Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.

Authors:  Aruni S Arachchige Don; Robert F Dallapiazza; David A Bennin; Tiffany Brake; Colleen E Cowan; Mary C Horne
Journal:  Exp Cell Res       Date:  2006-09-29       Impact factor: 3.905

3.  Using Trawler_standalone to discover overrepresented motifs in DNA and RNA sequences derived from various experiments including chromatin immunoprecipitation.

Authors:  Yannick Haudry; Mirana Ramialison; Benedict Paten; Joachim Wittbrodt; Laurence Ettwiller
Journal:  Nat Protoc       Date:  2010-02-04       Impact factor: 13.491

4.  Single factors direct the differentiation of stem cells from the fetal and adult central nervous system.

Authors:  K K Johe; T G Hazel; T Muller; M M Dugich-Djordjevic; R D McKay
Journal:  Genes Dev       Date:  1996-12-15       Impact factor: 11.361

5.  Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors.

Authors:  M Nieto; C Schuurmans; O Britz; F Guillemot
Journal:  Neuron       Date:  2001-02       Impact factor: 17.173

6.  Neurogenin2 specifies the connectivity of thalamic neurons by controlling axon responsiveness to intermediate target cues.

Authors:  Julie Seibt; Carol Schuurmans; Gérard Gradwhol; Colette Dehay; Pierre Vanderhaeghen; François Guillemot; Franck Polleux
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

7.  TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.

Authors:  Tae Jun Park; Ji Yeon Kim; S Paul Oh; So Young Kang; Bong Wan Kim; Hee Jung Wang; Kye Yong Song; Hyoung Chin Kim; In Kyoung Lim
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

8.  Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.

Authors:  Mitsunori Ota; Hiroshi Sasaki
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

9.  Neural stem cell transcriptional networks highlight genes essential for nervous system development.

Authors:  Tony D Southall; Andrea H Brand
Journal:  EMBO J       Date:  2009-12-16       Impact factor: 11.598

10.  Orphan nuclear receptor TLX activates Wnt/beta-catenin signalling to stimulate neural stem cell proliferation and self-renewal.

Authors:  Qiuhao Qu; Guoqiang Sun; Wenwu Li; Su Yang; Peng Ye; Chunnian Zhao; Ruth T Yu; Fred H Gage; Ronald M Evans; Yanhong Shi
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

View more
  181 in total

1.  Notch/Rbpjκ signaling regulates progenitor maintenance and differentiation of hypothalamic arcuate neurons.

Authors:  Paven K Aujla; George T Naratadam; Liwen Xu; Lori T Raetzman
Journal:  Development       Date:  2013-07-24       Impact factor: 6.868

Review 2.  Transcription-Factor-Dependent Control of Adult Hippocampal Neurogenesis.

Authors:  Ruth Beckervordersandforth; Chun-Li Zhang; Dieter Chichung Lie
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-10-01       Impact factor: 10.005

3.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

Review 4.  Circuit development in the master clock network of mammals.

Authors:  Vania Carmona-Alcocer; Kayla E Rohr; Deborah A M Joye; Jennifer A Evans
Journal:  Eur J Neurosci       Date:  2018-12-05       Impact factor: 3.386

5.  Rapid Chromatin Switch in the Direct Reprogramming of Fibroblasts to Neurons.

Authors:  Orly L Wapinski; Qian Yi Lee; Albert C Chen; Rui Li; M Ryan Corces; Cheen Euong Ang; Barbara Treutlein; Chaomei Xiang; Valérie Baubet; Fabian Patrik Suchy; Venkat Sankar; Sopheak Sim; Stephen R Quake; Nadia Dahmane; Marius Wernig; Howard Y Chang
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

6.  The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A.

Authors:  Mari Sepp; Hanna Vihma; Kaja Nurm; Mari Urb; Stephanie Cerceo Page; Kaisa Roots; Anu Hark; Brady J Maher; Priit Pruunsild; Tõnis Timmusk
Journal:  J Neurosci       Date:  2017-09-26       Impact factor: 6.167

Review 7.  Radial glia in the ventral telencephalon.

Authors:  Miguel Turrero García; Corey C Harwell
Journal:  FEBS Lett       Date:  2017-09-19       Impact factor: 4.124

8.  A transcription factor collective defines the HSN serotonergic neuron regulatory landscape.

Authors:  Carla Lloret-Fernández; Miren Maicas; Carlos Mora-Martínez; Alejandro Artacho; Ángela Jimeno-Martín; Laura Chirivella; Peter Weinberg; Nuria Flames
Journal:  Elife       Date:  2018-03-22       Impact factor: 8.140

9.  Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.

Authors:  Maike Zimmermann; Aruni P S Arachchige-Don; Michaela S Donaldson; Tommaso Patriarchi; Mary C Horne
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

10.  Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.

Authors:  Pedro Rosmaninho; Susanne Mükusch; Valerio Piscopo; Vera Teixeira; Alexandre Asf Raposo; Rolf Warta; Romina Bennewitz; Yeman Tang; Christel Herold-Mende; Stefano Stifani; Stefan Momma; Diogo S Castro
Journal:  EMBO J       Date:  2018-06-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.